Beta 2-microglobulin amyloidosis in renal failure: understanding this recently recognized condition.
Where this comes from
- Record sourced from PubMed, PMID 10079583.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Beta 2-microglobulin amyloidosis can cause significant suffering in patients with chronic renal failure. Although renal transplantation is currently the only treatment, medical and surgical therapies may decrease pain and disability.